Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCAT 2023 | An update on curative treatments for patients with thalassemia

Maria Domenica Cappellini, MD, University of Milan, Milan, Italy, discusses the history of thalassemia treatment, and provides updates on gene therapy and genome editing as curative treatments for patients with this disease. This interview was recorded at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.